VEGF and IGF Delivered from Alginate Hydrogels Promote Stable Perfusion Recovery in Ischemic Hind Limbs of Aged Mice and Young Rabbits

Erin M. Anderson, Eduardo Silva, Yibai Hao, Kathleen D. Martinick, Sarah A. Vermillion, Alexander G. Stafford, Elisabeth G. Doherty, Lin Wang, Edward J. Doherty, Paul M. Grossman, David J. Mooney

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Biomaterial-based delivery of angiogenic growth factors restores perfusion more effectively than bolus delivery methods in rodent models of peripheral vascular disease, but the same success has not yet been demonstrated in clinically relevant studies of aged or large animals. These studies explore, in clinically relevant models, a therapeutic angiogenesis strategy for the treatment of peripheral vascular disease that overcomes the challenges encountered in previous clinical trials. Alginate hydrogels providing sustained release of vascular endothelial growth factor (VEGF) and insulin-like growth factor-1 (IGF) were injected into ischemic hind limbs in middle-aged and old mice, and also in young rabbits, as a test of the scalability of this local growth factor treatment. Spontaneous perfusion recovery diminished with increasing age, and only the combination of VEGF and IGF delivery from gels significantly rescued perfusion in middle-aged (13 months) and old (20 months) mice. In rabbits, the delivery of VEGF alone or in combination with IGF from alginate hydrogels, at a dose 2 orders of magnitude lower than the typical doses used in past rabbit studies, enhanced perfusion recovery when given immediately after surgery, or as a treatment for chronic ischemia. Capillary density measurements and angiographic analysis demonstrated the benefit of gel delivery. These data together suggest that alginate hydrogels providing local delivery of low doses of VEGF and IGF constitute a safe and effective treatment for hind-limb ischemia in clinically relevant animal models, thereby supporting the potential clinical translation of this concept.

Original languageEnglish (US)
Pages (from-to)288-298
Number of pages11
JournalJournal of Vascular Research
Volume54
Issue number5
DOIs
StatePublished - Oct 1 2017

Fingerprint

Hydrogels
Somatomedins
Vascular Endothelial Growth Factor A
Extremities
Perfusion
Rabbits
Peripheral Vascular Diseases
Intercellular Signaling Peptides and Proteins
Ischemia
Gels
Angiogenesis Inducing Agents
Biocompatible Materials
Rodentia
Animal Models
Clinical Trials
alginic acid
Therapeutics

Keywords

  • Angiogenesis
  • Ischemia
  • Peripheral vascular disease

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine

Cite this

VEGF and IGF Delivered from Alginate Hydrogels Promote Stable Perfusion Recovery in Ischemic Hind Limbs of Aged Mice and Young Rabbits. / Anderson, Erin M.; Silva, Eduardo; Hao, Yibai; Martinick, Kathleen D.; Vermillion, Sarah A.; Stafford, Alexander G.; Doherty, Elisabeth G.; Wang, Lin; Doherty, Edward J.; Grossman, Paul M.; Mooney, David J.

In: Journal of Vascular Research, Vol. 54, No. 5, 01.10.2017, p. 288-298.

Research output: Contribution to journalArticle

Anderson, EM, Silva, E, Hao, Y, Martinick, KD, Vermillion, SA, Stafford, AG, Doherty, EG, Wang, L, Doherty, EJ, Grossman, PM & Mooney, DJ 2017, 'VEGF and IGF Delivered from Alginate Hydrogels Promote Stable Perfusion Recovery in Ischemic Hind Limbs of Aged Mice and Young Rabbits', Journal of Vascular Research, vol. 54, no. 5, pp. 288-298. https://doi.org/10.1159/000479869
Anderson, Erin M. ; Silva, Eduardo ; Hao, Yibai ; Martinick, Kathleen D. ; Vermillion, Sarah A. ; Stafford, Alexander G. ; Doherty, Elisabeth G. ; Wang, Lin ; Doherty, Edward J. ; Grossman, Paul M. ; Mooney, David J. / VEGF and IGF Delivered from Alginate Hydrogels Promote Stable Perfusion Recovery in Ischemic Hind Limbs of Aged Mice and Young Rabbits. In: Journal of Vascular Research. 2017 ; Vol. 54, No. 5. pp. 288-298.
@article{5974ebd7ccfd446592402a2acc49e08d,
title = "VEGF and IGF Delivered from Alginate Hydrogels Promote Stable Perfusion Recovery in Ischemic Hind Limbs of Aged Mice and Young Rabbits",
abstract = "Biomaterial-based delivery of angiogenic growth factors restores perfusion more effectively than bolus delivery methods in rodent models of peripheral vascular disease, but the same success has not yet been demonstrated in clinically relevant studies of aged or large animals. These studies explore, in clinically relevant models, a therapeutic angiogenesis strategy for the treatment of peripheral vascular disease that overcomes the challenges encountered in previous clinical trials. Alginate hydrogels providing sustained release of vascular endothelial growth factor (VEGF) and insulin-like growth factor-1 (IGF) were injected into ischemic hind limbs in middle-aged and old mice, and also in young rabbits, as a test of the scalability of this local growth factor treatment. Spontaneous perfusion recovery diminished with increasing age, and only the combination of VEGF and IGF delivery from gels significantly rescued perfusion in middle-aged (13 months) and old (20 months) mice. In rabbits, the delivery of VEGF alone or in combination with IGF from alginate hydrogels, at a dose 2 orders of magnitude lower than the typical doses used in past rabbit studies, enhanced perfusion recovery when given immediately after surgery, or as a treatment for chronic ischemia. Capillary density measurements and angiographic analysis demonstrated the benefit of gel delivery. These data together suggest that alginate hydrogels providing local delivery of low doses of VEGF and IGF constitute a safe and effective treatment for hind-limb ischemia in clinically relevant animal models, thereby supporting the potential clinical translation of this concept.",
keywords = "Angiogenesis, Ischemia, Peripheral vascular disease",
author = "Anderson, {Erin M.} and Eduardo Silva and Yibai Hao and Martinick, {Kathleen D.} and Vermillion, {Sarah A.} and Stafford, {Alexander G.} and Doherty, {Elisabeth G.} and Lin Wang and Doherty, {Edward J.} and Grossman, {Paul M.} and Mooney, {David J.}",
year = "2017",
month = "10",
day = "1",
doi = "10.1159/000479869",
language = "English (US)",
volume = "54",
pages = "288--298",
journal = "Journal of Vascular Research",
issn = "1018-1172",
publisher = "S. Karger AG",
number = "5",

}

TY - JOUR

T1 - VEGF and IGF Delivered from Alginate Hydrogels Promote Stable Perfusion Recovery in Ischemic Hind Limbs of Aged Mice and Young Rabbits

AU - Anderson, Erin M.

AU - Silva, Eduardo

AU - Hao, Yibai

AU - Martinick, Kathleen D.

AU - Vermillion, Sarah A.

AU - Stafford, Alexander G.

AU - Doherty, Elisabeth G.

AU - Wang, Lin

AU - Doherty, Edward J.

AU - Grossman, Paul M.

AU - Mooney, David J.

PY - 2017/10/1

Y1 - 2017/10/1

N2 - Biomaterial-based delivery of angiogenic growth factors restores perfusion more effectively than bolus delivery methods in rodent models of peripheral vascular disease, but the same success has not yet been demonstrated in clinically relevant studies of aged or large animals. These studies explore, in clinically relevant models, a therapeutic angiogenesis strategy for the treatment of peripheral vascular disease that overcomes the challenges encountered in previous clinical trials. Alginate hydrogels providing sustained release of vascular endothelial growth factor (VEGF) and insulin-like growth factor-1 (IGF) were injected into ischemic hind limbs in middle-aged and old mice, and also in young rabbits, as a test of the scalability of this local growth factor treatment. Spontaneous perfusion recovery diminished with increasing age, and only the combination of VEGF and IGF delivery from gels significantly rescued perfusion in middle-aged (13 months) and old (20 months) mice. In rabbits, the delivery of VEGF alone or in combination with IGF from alginate hydrogels, at a dose 2 orders of magnitude lower than the typical doses used in past rabbit studies, enhanced perfusion recovery when given immediately after surgery, or as a treatment for chronic ischemia. Capillary density measurements and angiographic analysis demonstrated the benefit of gel delivery. These data together suggest that alginate hydrogels providing local delivery of low doses of VEGF and IGF constitute a safe and effective treatment for hind-limb ischemia in clinically relevant animal models, thereby supporting the potential clinical translation of this concept.

AB - Biomaterial-based delivery of angiogenic growth factors restores perfusion more effectively than bolus delivery methods in rodent models of peripheral vascular disease, but the same success has not yet been demonstrated in clinically relevant studies of aged or large animals. These studies explore, in clinically relevant models, a therapeutic angiogenesis strategy for the treatment of peripheral vascular disease that overcomes the challenges encountered in previous clinical trials. Alginate hydrogels providing sustained release of vascular endothelial growth factor (VEGF) and insulin-like growth factor-1 (IGF) were injected into ischemic hind limbs in middle-aged and old mice, and also in young rabbits, as a test of the scalability of this local growth factor treatment. Spontaneous perfusion recovery diminished with increasing age, and only the combination of VEGF and IGF delivery from gels significantly rescued perfusion in middle-aged (13 months) and old (20 months) mice. In rabbits, the delivery of VEGF alone or in combination with IGF from alginate hydrogels, at a dose 2 orders of magnitude lower than the typical doses used in past rabbit studies, enhanced perfusion recovery when given immediately after surgery, or as a treatment for chronic ischemia. Capillary density measurements and angiographic analysis demonstrated the benefit of gel delivery. These data together suggest that alginate hydrogels providing local delivery of low doses of VEGF and IGF constitute a safe and effective treatment for hind-limb ischemia in clinically relevant animal models, thereby supporting the potential clinical translation of this concept.

KW - Angiogenesis

KW - Ischemia

KW - Peripheral vascular disease

UR - http://www.scopus.com/inward/record.url?scp=85029739313&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85029739313&partnerID=8YFLogxK

U2 - 10.1159/000479869

DO - 10.1159/000479869

M3 - Article

VL - 54

SP - 288

EP - 298

JO - Journal of Vascular Research

JF - Journal of Vascular Research

SN - 1018-1172

IS - 5

ER -